Jose M. Campos Tarrech-rekin lankidetzan egindako argitalpenak (7)

2004

  1. Dynamics of Long-Term Colonization of Respiratory Tract by Haemophilus influenzae in Cystic Fibrosis Patients Shows a Marked Increase in Hypermutable Strains

    Journal of Clinical Microbiology, Vol. 42, Núm. 4, pp. 1450-1459

  2. Laboratory Detection of Haemophilus influenzae with Decreased Susceptibility to Nalidixic Acid, Ciprofloxacin, Levofloxacin, and Moxifloxacin Due to gyrA and parC Mutations

    Journal of Clinical Microbiology, Vol. 42, Núm. 3, pp. 1185-1191

2003

  1. Activities of 13 quinolones by three susceptibility testing methods against a collection of Haemophilus influenzae isolates with different levels of susceptibility to ciprofloxacin: Evidence for cross-resistance

    Journal of Antimicrobial Chemotherapy, Vol. 51, Núm. 1, pp. 147-151

  2. Antibiotic resistance and clinical significance of Haemophilus influenzae type f

    Journal of Antimicrobial Chemotherapy, Vol. 52, Núm. 6, pp. 961-966

  3. In Vitro Activities of Garenoxacin (BMS-284756) against Haemophilus influenzae Isolates with Different Fluoroquinolone Susceptibilities

    Antimicrobial Agents and Chemotherapy, Vol. 47, Núm. 11, pp. 3539-3541

1996

  1. Ciprofloxacin-resistant Haemophilus influenzae strains possess mutations in analogous positions of GyrA and ParC

    Antimicrobial Agents and Chemotherapy, Vol. 40, Núm. 7, pp. 1741-1744

  2. Long-term persistence of ciprofloxacin-resistant Haemophilus influenzae in patients with cystic fibrosis

    Journal of Infectious Diseases, Vol. 174, Núm. 6, pp. 1345-1347